Restructuring and Other Charges	9 Months Ended
Apr. 30, 2026
Restructuring and Related Activities [Abstract]
Restructuring and Other Charges	Note 19. Restructuring and Other Charges During the first three quarters of fiscal 2026, the Company continued the global footprint and cost optimization actions to further improve the operating and manufacturing cost structure, which began in fiscal 2024. These activities resulted in restructuring and related expenses of $9.0 million and $7.5 million for the three and nine months ended April 30, 2026, respectively, and $3.0 million and $8.4 million for the three and nine months ended April 30, 2025, respectively. Charges of $9.1 million and $13.3 million were included in cost of sales, and benefits of $0.1 million and $5.8 million were included in operating expense in the Condensed Consolidated Statement of Earnings for the three and nine months ended April 30, 2026, respectively. Charges of $2.6 million and $4.3 million were included in cost of sales, and charges of $0.4 million and $4.1 million were included in operating expense in the Condensed Consolidated Statements of Earnings for the three and nine months ended April 30, 2025, respectively. The estimated range of future costs associated with actions related to this restructuring is $3.0 million to $5.0 million. As of April 30, 2026 and July 31, 2025, $5.5 million and $7.1 million, respectively, of accrued expenses were included in accrued employee compensation and related taxes in the Condensed Consolidated Balance Sheets.

Restructuring and Other Charges

9 Months Ended

Apr. 30, 2026

Restructuring and Related Activities [Abstract]

Note 19. Restructuring and Other Charges

During the first three quarters of fiscal 2026, the Company continued the global footprint and cost optimization actions to further improve the operating and manufacturing cost structure, which began in fiscal 2024. These activities resulted in restructuring and related expenses of $9.0 million and $7.5 million for the three and nine months ended April 30, 2026, respectively, and $3.0 million and $8.4 million for the three and nine months ended April 30, 2025, respectively. Charges of $9.1 million and $13.3 million were included in cost of sales, and benefits of $0.1 million and $5.8 million were included in operating expense in the Condensed Consolidated Statement of Earnings for the three and nine months ended April 30, 2026, respectively. Charges of $2.6 million and $4.3 million were included in cost of sales, and charges of $0.4 million and $4.1 million were included in operating expense in the Condensed Consolidated Statements of Earnings for the three and nine months ended April 30, 2025, respectively. The estimated range of future costs associated with actions related to this restructuring is $3.0 million to $5.0 million.

As of April 30, 2026 and July 31, 2025, $5.5 million and $7.1 million, respectively, of accrued expenses were included in accrued employee compensation and related taxes in the Condensed Consolidated Balance Sheets.